Navigation Links
Mindray Medical International Announces First Quarter 2008 Results
Date:5/7/2008

31, 2008 and June 30, 2008, and for the year ended December 31, 2007, with the announcement of its second quarter 2008 financial results.

Conference Call Information

Mindray's management will hold an earnings conference call at 8:00 a.m. on May 8, 2008 U.S. Eastern Time (8:00 p.m. on May 8, 2008 Beijing/Hong Kong Time).
Dial-in details for the earnings conference call are as follows:

Hong Kong: +852-3002-1672

US Toll Free: +1-800-706-7748

International: +1-617-614-3473

Passcode for all regions: Mindray A replay of the conference call may be accessed by phone at the following numbers until May 19, 2008.

US Toll Free: +1-888-286-8010

International: +1-617-801-6888

Passcode: 61704457

Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at http://www.mindray.com .

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products, and medical imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Moscow, Istanbul, London, Mexico City, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .

Use of Non-GAAP Financial Measures

The Company has reported (1) for the first quarter 2008 non-GAAP net income, operating income, and earnings per share on a non-GAAP basis and (2) for the estimated full year 2008 non-GAAP net income and earni
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Soy Peptone. HSP A has been found to be effectinve ... ... December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a ... rates and yields. HSP-A has been found to be especially ...
(Date:12/15/2009)... Dec. 15 Repligen Corporation (Nasdaq: ... received $731,000 in research funding to support the ... from the Muscular Dystrophy Association (MDA). This ... toxicology testing and GMP manufacture of a drug ... the MDA not only provides important funding for ...
(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...
(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2
... issued the,following response to a press release distributed on ... achieved in the AIPPI in,AGA,s patent dispute with Occlutech. ... conducted before the AIPPI and that,organization agreed with the ... not been involved in any proceedings with Occlutech,in which ...
... Co. (OTC Bulletin Board:,AYXC) announced today it has ... of MiMedx, Inc., a development-stage medical device,company, based ... transaction, structured as a reverse merger,Alynx issued approximately ... and,approximately 3.7 million new shares of its preferred ...
... PharmAthene, Inc., a,biodefense company developing medical ... that it has appointed Joan Fusco,Ph.D. Senior ... brings more than twenty years of experience ... experience in a variety of,functional areas including, ...
Other Biology Technology:AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe 2Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc. 2Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc. 3PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations 2PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations 3
(Date:12/16/2009)... every drop of water is a high priority for grape growers ... and vines have to be irrigated to make it through the ... of the water applied to the vines zips right by the ... percent of the water that is applied is lost below the ... and vine roots," said Eve Hinckley, who worked on the project ...
(Date:12/16/2009)... superstitions and rituals can help them get psyched up ... drugs (NSAIDs), which many athletes gobble down before and ... good. , "These agents are treatments for the symptoms ... Warden, whose research at Indiana University focuses on musculoskeletal ... to exercise or train at a certain level, but ...
(Date:12/16/2009)... 15, 2009 Signal Hill, CA Tom Bowman, ... and president of Bowman Global Change, has developed a ... fourth Intergovernmental Panel on Climate Change (IPCC) report for ... the authentic scientific information they need to make informed ... created the new format as a means to clearly ...
Breaking Biology News(10 mins):Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4NSAIDs: Take 'em early and often when competing? Think again 2Bowman creates graphic translation of climate change data 2Clarient Reports Second Quarter Revenue Up 40 Percent 53673 1Clarient Reports Second Quarter Revenue Up 40 Percent 53673 2Clarient Reports Second Quarter Revenue Up 40 Percent 53673 3Clarient Reports Second Quarter Revenue Up 40 Percent 53673 4Clarient Reports Second Quarter Revenue Up 40 Percent 53673 5Clarient Reports Second Quarter Revenue Up 40 Percent 53673 6Clarient Reports Second Quarter Revenue Up 40 Percent 53673 7Clarient Reports Second Quarter Revenue Up 40 Percent 53673 8Clarient Reports Second Quarter Revenue Up 40 Percent 53673 9Clarient Reports Second Quarter Revenue Up 40 Percent 53673 10National Courage Award Winner Jordan Thomas to Participate in PGA Adapted Youth Golf Clinic 53668 1National Courage Award Winner Jordan Thomas to Participate in PGA Adapted Youth Golf Clinic 53668 2BioSpecifics Technologies Corp to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12 2009 13362 1BioSpecifics Technologies Corp to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12 2009 13362 2
... have received a $1.08 million grant from New York through ... research on the growth and development of stem cells and ... role specific genes and biological molecules play in stem cell ... for the grants are Robert Linhardt, the Ann and John ...
... syndrome, was thought to function in endocytosis. In the March ... ( www.jcb.org ), Eastman et al. identify an unexpected ... , Cells transport excess fats into lipid droplets (LDs), where ... little is known about LD formation and regulation. Spartin hadn,t ...
... are used to thinking of heart disease as a product ... eat and how much we exercise. There is another road ... increase in particulate air pollution is associated with an increase ... relatively new field of environmental cardiology -- a field that ...
Other Biology News:Rensselaer receives more than $2 million from New York State to fund stem cell research 2Rensselaer receives more than $2 million from New York State to fund stem cell research 3Inhaling a heart attack: How air pollution can cause heart disease 2Inhaling a heart attack: How air pollution can cause heart disease 3
...
... Sequencing Quality 96 Well ... BAC template preparation from 1.5ml ... suitable for automated fluorescent sequencing ... DNA; Utilizes ProPrep strategy which ...
Hybridization Buffer 3.6 ml...
Olig2 Immunogen: Synthetic peptide from rat. Available Date: 9-19-2006...
Biology Products: